Madrigal Pharmaceuticals Inc (MDGL)

Other Income/Expenses (Net)

-$1.63M

Quarterly · Period ending: · USD

MDGL logo

MDGL Other Income/Expenses (Net)

Latest reported-$1.63M
MDGL Quarterly Other Income/Expenses (Net) (-$1.58M → -$1.63M)
High-resolution chart · PNG

MDGL other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Madrigal Pharmaceuticals Inc Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
-1,631,000
-1,668,000
1,034,000
-215,000
4,921,000
6,073,000
7,580,000
9,340,000
10,566,000
4,496,000
4,982,000
-206,000
650,000
1,440,000
-606,000
-785,000
-457,000
69,000
52,000
60,000
91,000
433,000
432,000
823,000
1,304,000
1,870,000
2,214,000
2,766,000
3,005,000
3,039,000
2,979,000
2,821,000
1,366,000
705,000
466,000
274,000
92,000
76,000
-66,475
-89,222
-238,000
-975,000
-156,000
-16,748,000
-296,000
-375,000
-458,000
-517,000
-585,000
-650,000
-718,000
-721,000
-724,000
-470,000
-29,677,000
-457,000
-486,000
-486,000
-37,141,000
-516,000
-493,000
-435,000
-29,102,000
-31,000
-30,000
-50,000
86,068,000
-53,000
-42,000,000
-64,000
-66,753,000
130,000
253,000
795,000
-105,737,000
519,000
725,000
377,000
-46,124,000
-351,000
0
0
0
0
0
641,000
-1,583,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.